Renoprotective effect of SGLT-2 inhibitors among type 2 diabetes patients with different baseline kidney function: a multi-center study.
Fang-Ju LinChi-Chuan WangChien-Ning HsuChen-Yi YangChih-Yuan WangHuang-Tz OuPublished in: Cardiovascular diabetology (2021)
This study supports the renoprotective benefit of real-world SGLT-2i use irrespective of patient baseline kidney function.